Global Longlife Hospital and Research shareholding pattern

GLHRL

15.39

1.65 (-9.68%)
Last updated on 1 Feb, 2026 | 10:51 IST
alert_iconwatchlist_icon
BUYSELL

alert_iconThe current prices are delayed, login to your account for live prices

Global Longlife Hospital and Research Shareholding Pattern

  • 2022-23
  • 2023-24
  • 2024-25
  • 2025-26
Total Promoters
Segment
Percent

Total Promoters

35.44%

Mutual Fund

0%

Insurance

0%

Foreign Institutional Investors

0%

Domestic Institutional Investors

0%

Retail

64.56%

Others

0%

Total Promoters
MAR '25
54.29%
JUN '25
54.9%
SEP '25
55.1%
DEC '25
35.44%

Summary

For Year 2025-26, Global Longlife Hospital and Research reports the following shareholding: Total Promoters at 35.44%, Mutual Fund at 0%, Insurance at 0%, Foreign Institutional Investors at 0%, Domestic Institutional Investors at 0%, and Retail at 64.56%. This breakdown provides a quick snapshot of ownership distribution for Global Longlife Hospital and Research in 2025-26.

Global Longlife Hospital and Research FAQs

As of 02-2026, the promoter shareholding in Global Longlife Hospital and Research stands at 35.44% of the company's total shares. Promoter shareholding represents the ownership stake held by the company's founding members, management, or controlling entities, having a significant influence on the company's strategic direction and operations.

The FII and DII shareholding of Global Longlife Hospital and Research is 0% and 0% respectively.

The retail shareholding of the Global Longlife Hospital and Research is 64.56%.

Changes in shareholding patterns of Global Longlife Hospital and Research can result from stock market transactions, issuance of new shares, buybacks, mergers, acquisitions, or changes in promoter holdings.

Shareholding patterns of Global Longlife Hospital and Research are updated quarterly as mandated by regulatory authorities and may also be disclosed during significant corporate events.

The latest shareholding pattern is available on stock exchanges (e.g., NSE, BSE) and the company's official website under investor relations.